Literature DB >> 7651431

Partial characterization of the human CYP1A1 negatively acting transcription factor and mutational analysis of its cognate DNA recognition sequence.

P D Boucher1, M P Piechocki, R N Hines.   

Abstract

Previous studies in our laboratory identified a negative regulatory domain in the 5'-flanking region of the human CYP1A1 gene containing two negative regulatory elements (NRE). Characterization of one of these elements revealed three nuclear protein binding regions: a 21-bp palindrome with a point of symmetry at -784 and two guanine- and cytosine-rich elements that flank the palindrome. Functional studies suggested the palindrome is critical for transcriptional repression, whereas the guanine- and cytosine-rich sequences play a secondary role. In this study, the interaction between nuclear proteins and the CYP1A1 NRE was further defined. Electrophoretic mobility shift assays (EMSA) indicated that the NRE -784 palindrome alone, but not the guanine- and cytosine-rich sequences minus the palindrome, was capable of specific nuclear protein binding. Competitive cotransfection experiments confirmed this observation in intact cells. Specific residues important for DNA-protein interactions were identified by site-directed mutagenesis and competitive EMSA. The loss of specific protein binding was also correlated with the loss of negative regulatory activity in a transient-expression assay. Finally, competitive EMSA was performed with consensus oligonucleotides for known transcription factors. An NF-Y consensus sequence efficiently competed with the NRE probe for specific nuclear protein binding. EMSA supershift analyses indicate that a protein immunologically related to NF-YB is part of the specific nuclear protein complex binding the human CYP1A1 NRE. These studies have refined our understanding of the sequences critical for the transcriptional repression of human CYP1A1. To our knowledge, this is also the first report implicating a member of the NF-Y transcription factor family in negative gene regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651431      PMCID: PMC230761          DOI: 10.1128/MCB.15.9.5144

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor.

Authors:  S N Maity; S Sinha; E C Ruteshouser; B de Crombrugghe
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

2.  Purification and properties of pregnancy-inducible rabbit lung cytochrome P-450 prostaglandin omega-hydroxylase.

Authors:  A S Muerhoff; D E Williams; B S Masters
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 3.  Transcriptional repression in eukaryotes.

Authors:  R Renkawitz
Journal:  Trends Genet       Date:  1990-06       Impact factor: 11.639

Review 4.  Regulation of steroid hydroxylase gene expression and steroid hormone biosynthesis.

Authors:  M R Waterman; J Lund; R Ahlgren; D Wu; E R Simpson
Journal:  Biochem Soc Trans       Date:  1990-02       Impact factor: 5.407

5.  Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas.

Authors:  T L McLemore; S Adelberg; M C Liu; N A McMahon; S J Yu; W C Hubbard; M Czerwinski; T G Wood; R Storeng; R A Lubet
Journal:  J Natl Cancer Inst       Date:  1990-08-15       Impact factor: 13.506

6.  Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP.

Authors:  D D Petersen; C E McKinney; K Ikeya; H H Smith; A E Bale; O W McBride; D W Nebert
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

7.  Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell lines.

Authors:  T L McLemore; S Adelberg; M Czerwinski; W C Hubbard; S J Yu; R Storeng; T G Wood; R N Hines; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1989-12-06       Impact factor: 13.506

8.  CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter.

Authors:  D G Skalnik; E C Strauss; S H Orkin
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

9.  Expression of cytochrome P450IA in breast cancer.

Authors:  G I Murray; C O Foster; T S Barnes; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

10.  Is aryl hydrocarbon hydroxylase activity a new prognostic indicator for breast cancer?

Authors:  K Pyykkö; R Tuimala; L Aalto; T Perkiö
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  4 in total

1.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

2.  An autoregulatory loop controlling CYP1A1 gene expression: role of H(2)O(2) and NFI.

Authors:  Y Morel; N Mermod; R Barouki
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 3.  A survey of 178 NF-Y binding CCAAT boxes.

Authors:  R Mantovani
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

4.  Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator.

Authors:  Brad R Evans; Sibel I Karchner; Lenka L Allan; Richard S Pollenz; Robert L Tanguay; Matthew J Jenny; David H Sherr; Mark E Hahn
Journal:  Mol Pharmacol       Date:  2007-11-13       Impact factor: 4.436

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.